About ClotPro
ClotPro is a Healthcare company based in Munchen (Germany) founded in 2017 by Andreas Calatzis, and was acquired by Haemonetics in April 2020. Provider of device for coagulation diagnostic. Its focus areas include Life Sciences, Hematology, Medical Devices and Monitoring.
Company details
ClotPro is a diagnostic instrument for the functional analysis of blood coagulation using Elastic Motion Thrombelastography (EMT). Tip technology is designed for reagent handling on the ClotPro analyzer. The reagents are present in a little sponge in the pipetting tip in dry form. During pipetting of the blood sample the reagents are transferred into the blood.
- Headquarters Munchen, Germany
- Founders Andreas Calatzis
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website clot.pro
- Acquired by Haemonetics (Apr 2020)
- Investors
- Acquired byHaemonetics
(Apr 2020)
Investors in ClotPro
ClotPro has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Haemonetics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Hematology products and solutions are provided for medical applications. | 1971 | haemonetics.com | Braintree, United States |
Investor details for ClotPro
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ClotPro
1 people are tracked at ClotPro (1 in leadership).
| Name | Role | Group |
|---|---|---|
Andreas Calatzis | Founder | Leadership |
Complete people profiles for ClotPro
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ClotPro
2 dated milestones of ClotPro across 3 years, from founding to its latest funding, stage changes and deals.
- Founded ClotPro is founded.
- Exit Acquired by Haemonetics.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ClotPro
ClotPro was founded in 2017.
ClotPro is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
ClotPro is a diagnostic instrument for the functional analysis of blood coagulation using Elastic Motion Thrombelastography (EMT). Tip technology is designed for reagent handling on the ClotPro analyzer. The reagents are present in a little sponge in the pipetting tip in dry form. During pipetting of the blood sample the reagents are transferred into the blood.
ClotPro has 1 investor. Key investors include Haemonetics.
Yes. ClotPro was acquired by Haemonetics in April 2020.